What causes alopecia areata?

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 4094373)

Published in Exp Dermatol on September 01, 2013


K J McElwee1, A Gilhar, D J Tobin, Y Ramot, J P Sundberg, M Nakamura, M Bertolini, S Inui, Y Tokura, L E King, B Duque-Estrada, A Tosti, A Keren, S Itami, Y Shoenfeld, A Zlotogorski, R Paus

Author Affiliations

1: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada. kmcelwee@mail.ubc.ca

Articles citing this

Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One (2014) 0.92

Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle. Biol Rev Camb Philos Soc (2014) 0.81

Vitiligo and alopecia areata: apples and oranges? Exp Dermatol (2013) 0.79

Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases. Oncotarget (2016) 0.77

Dietary vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle. Exp Biol Med (Maywood) (2014) 0.76

Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr (2016) 0.76

Two Episodes of Simultaneous Identical Alopecia Areata in Identical Twins. Int J Trichology (2016) 0.75

Renbök phenomenon in an alopecia areata patient with psoriasis. Int J Trichology (2013) 0.75

The role of lymphocytes in the development and treatment of alopecia areata. Expert Rev Clin Immunol (2015) 0.75

Alopecia Areata as a Manifestation of Systemic Lymphoma: Report of Two Cases. Skin Appendage Disord (2016) 0.75

CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata. J Immunol (2016) 0.75

Arctiin blocks hydrogen peroxide-induced senescence and cell death though microRNA expression changes in human dermal papilla cells. Biol Res (2014) 0.75

Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies. Autoimmun Rev (2016) 0.75

Lack of association between alopecia areata and HLA class I and II in a southeastern Brazilian population. An Bras Dermatol (2016) 0.75

Articles cited by this

(truncated to the top 100)

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15

Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23

Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2003) 12.34

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45

Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med (1999) 7.62

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 3.99

Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity (2009) 3.51

Multistep pathogenesis of autoimmune disease. Cell (2007) 3.36

WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism. Science (2006) 3.36

Decanalization and the origin of complex disease. Nat Rev Genet (2009) 3.12

Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature (2005) 2.89

Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature (2010) 2.85

Alopecia areata update. J Am Acad Dermatol (2000) 2.83


See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol (2006) 2.62

Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol (2008) 2.59

Alopecia areata. N Engl J Med (2012) 2.56

Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51

Dendritic cell subsets in health and disease. Immunol Rev (2007) 2.45

Bacterial superantigens. Clin Exp Immunol (2003) 2.42

Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest (1998) 2.27

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity (2007) 2.23

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17

Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc (1995) 1.99

TGF-beta: a mobile purveyor of immune privilege. Immunol Rev (2006) 1.90

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Developmental biology. The Turing model comes of molecular age. Science (2006) 1.77

Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol (2007) 1.71

Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med (1974) 1.65

Innate immune response to viral infection. Cytokine (2008) 1.63

Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol (2008) 1.62

Mouse models of psoriasis. J Invest Dermatol (2007) 1.58

Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56

The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today (1995) 1.56

Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet (2007) 1.55

Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol (2007) 1.54

Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol (2010) 1.48

The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47

Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46

Epidemiology and genetics of alopecia areata. Clin Exp Dermatol (2002) 1.45

Alopecia areata. Int J Dermatol (2007) 1.45

Alopecia areata update: part II. Treatment. J Am Acad Dermatol (2010) 1.44

Hair loss after routine immunizations. JAMA (1997) 1.43

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today (1995) 1.40

Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40

Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol (2004) 1.38

Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36

A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) (2008) 1.35

Histopathologic features of alopecia areata: a new look. Arch Dermatol (2003) 1.34

Role of macrophages in collagen resorption during hair growth cycle. J Ultrastruct Res (1969) 1.30

Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.30

A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol (1998) 1.29

Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol (2012) 1.28

Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol (1998) 1.27

Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest (1998) 1.27

Historical structure of scientific discovery. Science (1962) 1.26

Management of alopecia areata. BMJ (2010) 1.25

Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol (2008) 1.22

Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol (1999) 1.22

Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc (2004) 1.22

A 'hairy' privilege. Trends Immunol (2005) 1.21

CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis (2012) 1.20

Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol (2006) 1.19

Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol (1969) 1.19

Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol (2007) 1.18

Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol (2002) 1.17

Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol (2005) 1.16

Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol (2008) 1.16

Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol (1984) 1.13

Update on primary cicatricial alopecias. J Am Acad Dermatol (2005) 1.13

Antibodies to hair follicles in alopecia areata. J Invest Dermatol (1994) 1.13

Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol (2005) 1.13

The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc (1999) 1.13

Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol (2003) 1.12

Apoptosis in the hair follicle. J Invest Dermatol (2006) 1.12

Alopecia areata, vitiligo, scleroderma and ulcerative colitis. Proc R Soc Med (1974) 1.12

Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity (2009) 1.10

The hair follicle and immune privilege. J Investig Dermatol Symp Proc (2003) 1.10

Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol (2006) 1.10

In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J Immunol (2008) 1.10

A new classification of alopecia areata. Dermatologica (1965) 1.09

Alopecia areata - animal models. Clin Exp Dermatol (2002) 1.08

Celiac disease and alopecia areata: report of a new association. Gastroenterology (1995) 1.06

Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06

Coincidence of vitiligo, alopecia areata, onychodystrophy, localized scleroderma and lichen planus. Dermatologica (1979) 1.06

Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol (1992) 1.06

Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology (2008) 1.05

Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc (2003) 1.04

Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin (2012) 1.03

Alopecia areata during treatment with biologic agents. Arch Dermatol (2006) 1.03

Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol (2001) 1.02

Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: Report of five cases and review of the literature. J Eur Acad Dermatol Venereol (2011) 1.02

The cell biology of human hair follicle pigmentation. Pigment Cell Melanoma Res (2010) 1.02

Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J Investig Dermatol Symp Proc (1999) 1.02

Articles by these authors

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11

Antisense transcription in the mammalian transcriptome. Science (2005) 15.69

Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71

Real-space observation of a two-dimensional skyrmion crystal. Nature (2010) 7.08

Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88

Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (1979) 6.56

Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother (1991) 6.19

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58

Controls of hair follicle cycling. Physiol Rev (2001) 5.49

Magnetic control of ferroelectric polarization. Nature (2003) 5.23

Emergent phenomena at oxide interfaces. Nat Mater (2012) 4.97

Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43

Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39

Limb and skin abnormalities in mice lacking IKKalpha. Science (1999) 3.85

Near room-temperature formation of a skyrmion crystal in thin-films of the helimagnet FeGe. Nat Mater (2010) 3.73

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68

gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother (1989) 3.67

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood (1999) 3.53

On the process of cellular division in Escherichia coli: nucleotide sequence of the gene for penicillin-binding protein 3. Mol Gen Genet (1983) 3.43

Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett (1996) 3.40

Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell (1986) 3.34

Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol (2001) 3.26

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med (2001) 3.23

Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19

Light-dependent translocation of a phytochrome B-GFP fusion protein to the nucleus in transgenic Arabidopsis. J Cell Biol (1999) 3.14

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med (1998) 3.01

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

Diet-dependent shifts in the bacterial population of the rumen revealed with real-time PCR. Appl Environ Microbiol (2001) 2.98

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98

Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. Genes Dev (2001) 2.96

Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96

Skyrmion flow near room temperature in an ultralow current density. Nat Commun (2012) 2.87

Observation of skyrmions in a multiferroic material. Science (2012) 2.86

Collective bulk carrier delocalization driven by electrostatic surface charge accumulation. Nature (2012) 2.80

Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78

Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol (1998) 2.76

MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75

Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation (1995) 2.73

Rheumatology in Israel. Br J Rheumatol (1996) 2.66

Self-organization of microtubule asters induced in Xenopus egg extracts by GTP-bound Ran. Science (1999) 2.59

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol (1992) 2.54

Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53

The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol (1996) 2.50

Giant Rashba-type spin splitting in bulk BiTeI. Nat Mater (2011) 2.49

Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48

Nucleotide sequence of the asnA gene coding for asparagine synthetase of E. coli K-12. Nucleic Acids Res (1981) 2.42

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus (2000) 2.40

Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol (2003) 2.35

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31

Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28

Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature (1991) 2.28

Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22

Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22

Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21

Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem (1999) 2.19

Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol (2001) 2.17

Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 2.17

Hair diameter diversity: a clinical sign reflecting the follicle miniaturization. Arch Dermatol (2001) 2.16

Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16

Functional assignment of the ORF2-iscS-iscU-iscA-hscB-hscA-fdx-ORF3 gene cluster involved in the assembly of Fe-S clusters in Escherichia coli. J Biochem (1999) 2.15

The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol (1998) 2.13

Unusual Hall effect anomaly in MnSi under pressure. Phys Rev Lett (2009) 2.12

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09

Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09

Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08

Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy. Clin Exp Dermatol (2009) 2.08

Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol (1999) 2.07

Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res (2002) 2.06

Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05

Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun (2007) 2.05

Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol (1989) 2.03

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02

Anomalous origin of the left coronary artery from the pulmonary artery. New operative technique. J Thorac Cardiovasc Surg (1993) 2.02

Two cases of bilateral bronchial artery varices: one with and one without bilateral coronary-to-pulmonary artery fistulas. Review and characterization of the clinical features of bronchial artery varices reported in Japan. Clin Radiol (2012) 2.00

Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A (1997) 1.97

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (2007) 1.97

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest (1998) 1.95

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92

Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol (1991) 1.92

MRI of cervical intervertebral discs in asymptomatic subjects. J Bone Joint Surg Br (1998) 1.92

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91

Possible relationship of a 36-megadalton Salmonella enteritidis plasmid to virulence in mice. Infect Immun (1985) 1.91

Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A (1999) 1.91

An invasive spirochaete associated with interdigital papillomatosis of dairy cattle. Vet Rec (1992) 1.90

Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89

Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol (2003) 1.89

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol (2009) 1.89